US 11434233
Heterocyclic inhibitors of ATR kinase
granted A61KA61K2300/00A61K45/06
Quick answer
US patent 11434233 (Heterocyclic inhibitors of ATR kinase) held by The Board of Regents of the University of Texas System expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2300/00, A61K45/06, A61P, A61P35/00